参考文献/References:
［1］廉静．雌孕激素联合甲硝唑治疗围绝经期女性萎缩性阴道炎的疗效 ［J］．饮食保健，2016，3（15）：64．
［2］孙艳．甲硝唑栓结合雌激素软膏治疗老年性阴道炎的疗效分析 ［J］．中国全科医学，2012，15（3）：318-320．
［3］金雪静，陈游沓，蔡平生，等．萎缩性阴道炎患者雌激素治疗后阴道局部环境的变化 ［J］．中华老年医学杂志，2014，33（10）：1107-1108．
［4］刘菁．重组人干扰素α-2b阴道泡腾胶囊联合氯喹那多-普罗雌烯阴道片治疗萎缩性阴道炎的临床观察 ［J］．四川医学，2013，34（3）：420-421．
［5］PORTMAN D, SHULMAN L, YEAW J, et al One-year treatment persistence with local estrogen therapy in postmenopausal women diagnosed as having vaginal atrophy ［J］. Menopause (New York, N.Y.), 2015, 22(11): 1197-1203.
［6］刘莹．雌三醇联合乳酸菌治疗萎缩性阴道炎疗效观察 ［J］．中国基层医药，2014，21（19）：2985-2986．
［7］陈国芬．理性情绪疗法对雌三醇联合乳酸菌治疗萎缩性阴道炎患者自我效能及自我管理能力的影响 ［J］．中国药业，2015，24（19）：107-109．
［8］WEBER M A, LIMPENS J, ROOVERS J P. Assessment of vaginal atrophy: a review ［J］. International Urogynecology Journal, 2015, 26(1): 15-28.
［9］王月利．雌激素联合甲硝唑阴道给药治疗萎缩性阴道炎的疗效与安全性分析 ［J］．中国医师进修杂志，2013,36（36）：41-42．
［10］王俊．雌三醇乳膏联合康妇特栓治疗复发性萎缩性阴道炎的临床观察 ［J］．老年医学与保健，2015，21（6）：377-379．
［11］NICHOLS W A, BIRKE L, DUFOUR J, et al. Characterization of the genital microenvironment of female rhesus macaques prior to and after SIV infection ［J］. American Journal of Reproductive Immunology (New York, N.Y. : 1989), 2015, 74(6): 508-522.
［12］DOLS J A, MOLENAAR D, VAN DER HELM J J, et al. Molecular assessment of bacterial vaginosis by Lactobacillus abundance and species diversity ［J］. BMC Infectious Diseases, 2016, 16(1): 180.
［13］ABDELMAKSOUD A A, KOPARDE V N, SHETH N U, et al. Comparison of lactobacillus crispatus isolates from lactobacillus-dominated vaginal microbiomes with isolates from microbiomes containing bacterial vaginosis-associated bacteria ［J］. Microbiology-SGM, 2016, 162(3): 466-475.
［14］赵品红，徐琳，李楠，等．保妇康凝胶与乳酸杆菌治疗非特异性阴道炎的疗效观察 ［J］．中国妇幼保健，2015，30（12）：1949-1950．
［15］COLLINS S, BEIGI R, MELLEN C, et al. The effect of pessaries on the vaginal microenvironment ［J］. American Journal of Obstetrics and Gynecology, 2015, 212(1): 60.e1-60.e6.
［16］DONCEL G F, ANDERSON S, ZALENSKAYA I. Role of semen in modulating the female genital tract microenvironment——implications for HIV transmission ［J］. American Journal of Reproductive Immunology (New York, N.Y. : 1989), 2014, 71(6): 564-574.
［17］MELKUMYAN A R, PRIPUTNEVICH T V, ANKIRSKAYA A , et al. Effects of antibiotic treatment on the lactobacillus composition of vaginal microbiota ［J］. Bulletin of Experimental Biology and Medicine, 2015, 158(6): 766-768.
［18］NASIOUDIS D, BEGHINI J, BONGIOVANNI A M, et al. α-Amylase in vaginal fluid: association with conditions favorable to dominance of lactobacillus ［J］. Reproductive Sciences (Thousand Oaks, Calif.), 2015, 22(11): 1393-1398.
［19］Donders G,Neven P,Moegele M,et al.Ultra-low-dose estrioland Lactobacillus acidophilus vaginal tablets (Gynoflor) for vaginal atrophy in postmenopausal breast cancer patients onaromatase inhibitors:pharmacokinetic,safety,and efficacy phase I clinical study ［J］.Breast Cancer Res Treat,145(2):371-379.
［20］邓琼，黄利川，江丹丹，等．乳酸杆菌联合甲硝唑治疗妊娠合并滴虫性阴道炎的临床分析 ［J］．中国性科学，2016，25（1）：122-125．
相似文献/References:
[1]霍艳芬*,霍墨杰,苏俊泽.重组人干扰素α-2 b凝胶联合乳酸菌阴道胶囊治疗高危型人乳头瘤病毒感染的临床观察[J].中国计划生育和妇产科,2018,(5):45.
HUO Yan-fen*,HUO Mo-jie,SU Jun-ze.Clinical observation of recombinant human interferon alpha -2b gel combined with lacidophilin vaginal capsules in the treatment of high risk human papillomavirus infection[J].Chinese Journal of Family Planning & Gynecotokology,2018,(7):45.